Filing Details

Accession Number:
0001209191-23-016252
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-06 16:11:13
Reporting Period:
2023-03-02
Accepted Time:
2023-03-06 16:11:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885978 U S Physical Therapy Inc USPH Services-Health Services (8000) 760364866
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1519948 D. Graham Reeve 1300 W Sam Houston Pkwy S
Suite 300
Houston TX 77042
Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-03-02 1,912 $100.95 8,243 No 4 S Indirect Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 17,062 Direct
Footnotes
  1. Includes 17,062 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,724 shares on each of April 1, 2023, July 1, 2023, October 1, 2023; 1,730 shares on January 1, 2024; 1,286 shares on each of April 1, 2024, July 1, 2024, October 1, 2024 and January 1, 2025; 936 shares on each of April 1, 2025 July 1, 2025 and October 1, 2025; 952 shares on January 1, 2026; and 312 shares on each of April 1, 2026, July 1, 2026 and October 1, 2026; and the final 320 shares on January 1, 2027, if he is an employee of the Company on those dates.
  2. The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $100.73 to $101.00, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.